These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3655157)

  • 21. Acyl enzymes for thrombolytic therapy.
    Walker ID; Davidson JF
    Semin Thromb Hemost; 1987 Apr; 13(2):139-45. PubMed ID: 3306926
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of thrombolytic therapy in unstable angina: clinical and angiographic results.
    de Zwaan C; Bar FW; Janssen JH; de Swart HB; Vermeer F; Wellens HJ
    J Am Coll Cardiol; 1988 Aug; 12(2):301-9. PubMed ID: 3134480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Morphologic manifestations of the medicinal lysis of a coronary artery thrombus].
    Permiakov NK; Galankina IE
    Kardiologiia; 1988 May; 28(5):33-6. PubMed ID: 3045402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New methods of thrombolysis].
    Vinazzer H
    Wien Med Wochenschr; 1987 Jun; 137(10-11):221-4. PubMed ID: 2955574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithrombotic therapy in acute coronary syndromes.
    Watson RD; Chin BS; Lip GY
    BMJ; 2002 Dec; 325(7376):1348-51. PubMed ID: 12468488
    [No Abstract]   [Full Text] [Related]  

  • 26. [General principles of thrombolysis].
    Brochier ML; Charbonnier B
    Arch Mal Coeur Vaiss; 1988 May; 81 Spec No():13-7. PubMed ID: 3142395
    [No Abstract]   [Full Text] [Related]  

  • 27. [Thrombolytic treatment of type A right atrial thrombi].
    Greco F
    G Ital Cardiol; 1999 Aug; 29(8):937-8. PubMed ID: 10488457
    [No Abstract]   [Full Text] [Related]  

  • 28. [The mode of action and clinical applications of phosphodiesterase inhibitors as anti-platelet drugs].
    Murohara Y; Takatsu Y; Yui Y; Kawai C
    Nihon Rinsho; 1989 Apr; 47(4):935-9. PubMed ID: 2545947
    [No Abstract]   [Full Text] [Related]  

  • 29. Successful thrombolytic treatment of right sided massive intracardiac thrombus and pulmonary embolism.
    Sen T; Astarcioglu MA; Erez SO; Yaymaci M; Pinar M; Parspur A; Amasyali B
    Kardiol Pol; 2014; 72(3):282. PubMed ID: 24677080
    [No Abstract]   [Full Text] [Related]  

  • 30. [An experimental study on thrombolysis in canine coronary artery by snake venom antithrombase II].
    Pang W
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Oct; 19(5):325-7. PubMed ID: 1817021
    [No Abstract]   [Full Text] [Related]  

  • 31. An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis.
    Marder VJ; Francis CW
    Prog Hemost Thromb; 1984; 7():325-56. PubMed ID: 6241729
    [No Abstract]   [Full Text] [Related]  

  • 32. Coronary thrombolysis--a Pakistani perspective.
    Khan B
    J Pak Med Assoc; 1991 May; 41(5):113-6. PubMed ID: 1861356
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of thrombolytic agents on coronary recanalization and patency, cardiac enzyme release, left ventricular function, and mortality in patients with acute myocardial infarction.
    Verstraete M
    J Cardiovasc Pharmacol; 1989; 14 Suppl 9():S38-48. PubMed ID: 2483231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombotic therapy after myocardial reperfusion in acute myocardial infarction.
    Fuster V; Stein B; Badimon L; Chesebro JH
    J Am Coll Cardiol; 1988 Dec; 12(6 Suppl A):78A-84A. PubMed ID: 3057038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombolysis with recombinant human single-chain urokinase-type plasminogen activator (rscu-PA): dose-response in dogs with coronary artery thrombosis.
    Van de Werf F; Jang IK; Collen D
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):91-3. PubMed ID: 2434801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary thrombolysis--a perspective for the practicing physician.
    Fuster V
    N Engl J Med; 1993 Sep; 329(10):723-5. PubMed ID: 8345859
    [No Abstract]   [Full Text] [Related]  

  • 37. Factors contributing to the emergence of coronary thrombolysis.
    Tiefenbrunn AJ; Sobel BE
    Cardiol Clin; 1987 Feb; 5(1):49-53. PubMed ID: 3103920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo models of arterial thrombosis and thrombolysis.
    Bush LR; Shebuski RJ
    FASEB J; 1990 Oct; 4(13):3087-98. PubMed ID: 2210155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombolytic therapy. A new strategy for the treatment of acute myocardial infarction (1).
    Laffel GL; Braunwald E
    N Engl J Med; 1984 Sep; 311(11):710-7. PubMed ID: 6382006
    [No Abstract]   [Full Text] [Related]  

  • 40. Problems of thrombolytic therapy.
    Neilson RF; Davidson JF
    Adverse Drug React Toxicol Rev; 1996 Mar; 15(1):51-64. PubMed ID: 8920633
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.